Clinical Trials

Showing trials with last updates posted in 2018.

NCT01776008 | TERMINATED | PHASE2
16 participants

Akt Inhibitor MK-2206 and Anastrozole With or Without Goserelin Acetate in Treating Patients With Stage II-III Breast Cancer

Study Type:
INTERVENTIONAL
Last Updated:
2018-05-08
Start Date:
2013-01-31
Completion:
2015-05-31
Conditions
  • Estrogen Receptor Positive
  • HER2/Neu Negative
  • Recurrent Breast Carcinoma
  • Stage IIA Breast Cancer
  • Stage IIB Breast Cancer
  • Stage IIIA Breast Cancer
  • Stage IIIB Breast Cancer
  • Stage IIIC Breast Cancer
Interventions
  • DRUG
  • OTHER
  • PROCEDURE
Previous
Sorted by latest updates
Next
Showing 40 trials per page